NASDAQ:ALBT

Avalon GloboCare (ALBT) Stock Forecast, Price & News

$2.08

-0.04 (-1.89%)

(As of 03:59 PM ET)

Compare

Today's Range: $2.07
▼
$2.19
50-Day Range: $1.68
▼
$2.28
52-Week Range: $1.65
▼
$8.05

Volume: 7,941 shs
Average Volume: 140,237 shs
Market Capitalization: $21.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Avalon GloboCare (NASDAQ:ALBT) Stock

Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.

Receive ALBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter.

ALBT Stock News Headlines

May 25, 2023 | americanbankingnews.com

Avalon GloboCare (NASDAQ:ALBT) Releases Earnings Results

May 16, 2023 | benzinga.com

Avalon Globocare Stock (NASDAQ:ALBT), Insider Trading Activity

June 9, 2023 | Vantage Point (Ad)

Trade Smarter: Discover Hidden Opportunities w/ A.I.

There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.

May 3, 2023 | americanbankingnews.com

Contrasting Avalon GloboCare (NASDAQ:ALBT) & ATIF (NASDAQ:ATIF)

April 27, 2023 | proactiveinvestors.com

Avalon GloboCare highlights the 2022 results of its latest investment, Laboratory Services MSO

April 27, 2023 | finance.yahoo.com

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

April 25, 2023 | americanbankingnews.com

Analyzing Avalon GloboCare (NASDAQ:ALBT) & TSS (OTCMKTS:TSSI)

April 17, 2023 | proactiveinvestors.com

Avalon GloboCare to launch its KetoAir breathalyzer device in North America at upcoming conference

June 9, 2023 | Behind the Markets (Ad)

"Unknown laser company making HUGE profit from Russia-Ukraine War"

On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>

April 17, 2023 | finance.yahoo.com

Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 Conference

April 11, 2023 | proactiveinvestors.com

Avalon GloboCare inks deal with Qi Diagnostics for distribution of KetoAir breathalyzer

April 11, 2023 | finance.yahoo.com

Avalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Union

March 23, 2023 | americanbankingnews.com

Financial Contrast: Booz Allen Hamilton (NYSE:BAH) versus Avalon GloboCare (NASDAQ:ALBT)

February 28, 2023 | seekingalpha.com

ALBT Avalon GloboCare Corp.

February 13, 2023 | msn.com

Avalon GloboCare acquires 40% interest in Laboratory Services MSO for $21M

February 13, 2023 | proactiveinvestors.com

Avalon GloboCare excited as it closes earnings accretive investment in testing firm

February 13, 2023 | finance.yahoo.com

Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company

January 17, 2023 | proactiveinvestors.com

Avalon GloboCare says it has been issued with a US patent for multiple novel QTY-code modified cytokine and chemokine protein receptor molecules

January 17, 2023 | finance.yahoo.com

Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules

January 11, 2023 | proactiveinvestors.com

Avalon GloboCare appoints Lourdes Felix, CEO of a premier addiction treatment company, to its board

January 11, 2023 | finance.yahoo.com

Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors

January 3, 2023 | finanznachrichten.de

Avalon GloboCare Corp.: Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

January 3, 2023 | proactiveinvestors.com

Avalon GloboCare reveals deployment of breakthrough fusion gene map technology

January 3, 2023 | finance.yahoo.com

Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

December 14, 2022 | proactiveinvestors.com

Avalon GloboCare raises $4M in Series A preferred stock to fund Laboratory Services MSO acquisition

December 14, 2022 | finance.yahoo.com

Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Company’s Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services

December 12, 2022 | proactiveinvestors.com

Avalon GloboCare to continue US-centric strategy with new proposed board composition ahead of Laboratory Services MSO acquisition

See More Headlines

ALBT Price History

30 days | 90 days | 365 days | Advanced Chart

ALBT Company Calendar

Last Earnings: 5/22/2023
Today: 6/09/2023
Next Earnings (Estimated): 8/04/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ALBT
CUSIP: N/A
CIK: 1630212
Web: www.avalon-globocare.com
Phone: (732) 780-4400
Fax: 732-780-5600
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-11,930,000.00
Net Margins: -1,053.75%
Pretax Margin: -1,053.67%
Return on Equity: -662.37%
Return on Assets: -61.12%

Debt

Debt-to-Equity Ratio: 2.11
Current Ratio: 0.27
Quick Ratio: 0.27

Sales & Book Value

Annual Sales: $1.20 million
Price / Sales: 17.95
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.22 per share
Price / Book: 9.64

Miscellaneous

Outstanding Shares: 10,160,000
Free Float: 3,659,000
Market Cap: $21.54 million
Optionable: Not Optionable
Beta: 0.55

Key Executives

David K. Jin
President, Chief Executive Officer & Director

Sarah Cox
Chief Operating Officer & Director

Luisa I. Ingargiola
Chief Financial Officer

Meng Li
Secretary & Chief Marketing Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ALBT Stock - Frequently Asked Questions

How have ALBT shares performed in 2023?: Avalon GloboCare's stock was trading at $5.20 at the beginning of 2023. Since then, ALBT shares have decreased by 59.2% and is now trading at $2.12.
View the best growth stocks for 2023 here.
When is Avalon GloboCare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our ALBT earnings forecast.
How were Avalon GloboCare's earnings last quarter?: Avalon GloboCare Corp. (NASDAQ:ALBT) posted its quarterly earnings results on Monday, May, 22nd. The company reported ($0.28) EPS for the quarter. The firm had revenue of $0.30 million for the quarter. Avalon GloboCare had a negative net margin of 1,053.75% and a negative trailing twelve-month return on equity of 662.37%.
When did Avalon GloboCare's stock split?: Avalon GloboCare's stock reverse split on Tuesday, January 3rd 2023. The 1-10 reverse split was announced on Tuesday, January 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Avalon GloboCare's stock symbol?: Avalon GloboCare trades on the NASDAQ under the ticker symbol "ALBT."
Who are Avalon GloboCare's major shareholders?: Avalon GloboCare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.20%), State Street Corp (0.19%) and Geode Capital Management LLC (0.17%).
How do I buy shares of Avalon GloboCare?: Shares of ALBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Avalon GloboCare's stock price today?: One share of ALBT stock can currently be purchased for approximately $2.12.
How much money does Avalon GloboCare make?: Avalon GloboCare (NASDAQ:ALBT) has a market capitalization of $21.54 million and generates $1.20 million in revenue each year.
How can I contact Avalon GloboCare?: Avalon GloboCare's mailing address is 4400 ROUTE 9 SOUTH SUITE 3100, FREEHOLD NJ, 07728. The official website for the company is www.avalon-globocare.com. The company can be reached via phone at (732) 780-4400, via email at avco@crescendo-ir.com, or via fax at 732-780-5600.

This page (NASDAQ:ALBT) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial